Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
17,553,121
-
Total 13F shares
-
723,145
-
Share change
-
+723,137
-
Total reported value
-
$5,257,398
-
Price per share
-
$7.27
-
Number of holders
-
28
-
Value change
-
+$5,257,337
-
Number of buys
-
26
Institutional Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) as of Q1 2023
As of 31 Mar 2023,
Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
723,145 shares.
The largest 10 holders included
Ikarian Capital, LLC, VANGUARD GROUP INC, Sio Capital Management, LLC, BlackRock Inc., BOOTHBAY FUND MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, Virtu Financial LLC, and Tekla Capital Management LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.